Docencia
Seleccionar una categoría >>
Disparities in the Quality of Cardiovascular Care Between HIV-Infected Versus HIVUninfected Adults in the United States: A Cross-Sectional Study
Dra. Ana Mariño. Unidad de VIH. Hospital Arquitecto Marcide-Novoa Santos, A Coruña.
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial
Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance ofHIV viral suppression in patients with high cardiovascular
Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review andmeta-regression analysis
Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older
Dr. Ana Mariño. Unidad de VIH del Hospital Arquitecto Marcide-Novoa Santos
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, noninferiority trial
Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella
Antiretroviral combination use during pregnancy and the risk of major congenital malformations
Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas Hospital Universitario y Politécnico la Fe, Valencia
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
Dra. Matilde Sánchez Conde. Infectious Diseases Unit Hospital Ramón y Cajal, Madrid
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of randomised, open-label, phase 2b, non-inferiority trial
Dr. Arkaitz Imaz. Infectious Diseases Unit Hospital de Bellvitge, Barcelona
Tolerability of Integrase Inhibitors in a Real-Life Setting
Dr. Esteban Martínez. Infectious Diseases Unit Hospital Clínic, University of Barcelona
Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort
Dra. Ana Mariño. Unidad de VIH Hospital Arquitecto Marcide-Novoa Santos
Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial
Dr. Adrian Currán Atencion sanitaria y hospitalaria Hospital Universitari de la Vall d´Hebron
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers
Dr. José Ramón Blanco. Investigador de la Unidad de VIH y Alteraciones Metabólicas Asociadas. Centro de investigación Biomédica de La Rioja
Eradication of HCV and non–liver-related non–AIDS-related events in HIV/HCV coinfection
Dra. Marisa Montes. Unidad de enfermedades infecciosas. Hospital Universitario de la Paz
Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4)
Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella
Impact of the Centers for Disease Control’s HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States
Dra. Concha Amador. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients A Cohort Study
Dr. Adrian Currán. Atencion sanitaria y hospitalaria. Hospital Universitari de la Vall d´Hebron.
